7Baggers
 published on: 2025-11-13 11:55:52  newser.com Thu, 13 Nov 2025 17:55:52 GMT
 form 8-k - current report  ADVFN Thu, 13 Nov 2025 08:50:32 GMT
 Published on: 2025-11-13 01:07:52  newser.com Thu, 13 Nov 2025 07:07:52 GMT
 Javier Palomarez, President of USHBC, Congratulates Ardelyx on Be  The National Law Review Thu, 13 Nov 2025 00:20:33 GMT
 ardelyx at wedbush rewind asn 2025: navigating medicare and market dynamics  Investing.com Nigeria Mon, 10 Nov 2025 20:45:17 GMT
 ardelyx presents positive real-world data for kidney disease drug xphozah  Investing.com Nigeria Fri, 07 Nov 2025 23:31:47 GMT
 ardelyx reports xphozah cuts phosphate levels in dialysis patients  MarketScreener Fri, 07 Nov 2025 21:40:40 GMT
 [form 3] ardelyx, inc. initial statement of beneficial ownership  Stock Titan Fri, 07 Nov 2025 21:04:50 GMT
 ardelyx: impressive q3 record growth - why i buy (nasdaq:ardx)  Seeking Alpha Wed, 05 Nov 2025 09:24:07 GMT
 Ardelyx: Impressive Q3 Record Growth—Why I Buy (NASDAQ:ARDX)  Seeking Alpha Wed, 05 Nov 2025 08:00:00 GMT
 ardelyx (nasdaq:ardx) given new $11.00 price target at citigroup  MarketBeat Tue, 04 Nov 2025 21:21:29 GMT
 ardelyx files automatic mixed securities shelf  MSN Tue, 04 Nov 2025 16:20:05 GMT
 Ardelyx: A Long Overdue Rally (NASDAQ:ARDX)  Seeking Alpha Tue, 04 Nov 2025 08:00:00 GMT
 Ardelyx price target raised to $10 from $9 at Piper Sandler  TipRanks Tue, 04 Nov 2025 08:00:00 GMT
 Citigroup Maintains Ardelyx (ARDX) Buy Recommendation  Nasdaq Mon, 03 Nov 2025 08:00:00 GMT
 hc wainwright forecasts ardelyx's q2 earnings (nasdaq:ardx)  MarketBeat Mon, 03 Nov 2025 08:00:00 GMT
 weekly update: q3 earnings from ardelyx and transmedics (nasdaq:ardx)  Seeking Alpha Mon, 03 Nov 2025 00:23:32 GMT

Ardelyx, Inc
(NASDAQ:ARDX) 

ARDX stock logo

Ardelyx, Inc., a biopharmaceutical company, develops and sells medicines for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase 3 clinical trial for the treatment of patients with irr...

Founded: 2007
Full Time Employees: 88
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends